Ab Initio CEO gives Keynote opening speech at the Annual Drug Discovery Initiative ECR Symposium

Ab Initio CEO Prof Paul Young gave the opening Keynote talk at this years ECR Drug Discovery Initiative Symposium.

Dr Young talked about the challenges that early career researchers face when commencing a career in Therapeutic drug development, talking about the pitfalls that should be avoided when developing a new drug. The Symposium brought together over 100 ECR researchers focussing on drug discovery and is a key annual symposium of the Drug Discovery Initiative at the University of Sydney. You can learn more about the Drug Discovery Initiative here.

You can learn how Ab Initio takes a new chemical entity and turns it in a GMP clinical trial ready product here